Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000-2004

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 3, 2007, Pages 189-194

  Vasilev, V ^a   Japheth, R ^a   Yishai, R ^a   Andorn, N ^a   Valinsky, L ^a   Navon Venezia, S ^b   Chmelnitsky, I ^b   Carmeli, Y ^b   Cohen, D ^c  

^a MINISTRY OF HEALTH   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE; SULBACTAM; TAZOBACTAM;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY HOSPITAL; CONTROLLED STUDY; ENZYME ANALYSIS; GENE TRANSFER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SHIGELLA BOYDII; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

EID: 34248214191     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0263-y     Document Type: Article

References (44)

1. Ahamed J, Kundu M (1999) Molecular characterization of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrob Agents Chemother 43:2081-2083
2. Jeong YS, Lee JC, Kang HY, Yu HS, Lee EY, Choi CH, Tae SH, Lee YC, Cho DT, Seol SY (2003) Epidemiology of nalidixic acid resistance and TEM-1- and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000. Antimicrob Agents Chemother 47:3719-3723
3. Schumacher H, Nir M, Mansa B, Grassy A (1992) β-Lactamases in Shigella. APMIS 100:954-956
4. Livermore DM (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557-584
5. Walter-Rasmussen J, Høiby N (2004) Cefotaximases (CTX-Mases), an expanding family of extended-spectrum β-lactamases. Can J Microbiol 50:137-165
6. Bonnet R (2004) Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1-14
7. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore D (2004) Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 54:735-743
8. CTX-M genes. Clin Infect Dis 38:1736-1741
9. Pallecci L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, Paradisi F, Kronvall G, Rossolini GM (2004) Detection of CTX-M-type β-lactamase gene in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 48:4556-4561
10. Bou G, Cartelle M, Tomas M, Canle D, Molina F, Moure R, Eiros JM, Guerrero A (2002) Identification and broad dissemination of CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol 40:4030-4036
11. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925-934
12. Borer A, Gilad J, Menashe G, Peled N, Reisenberg K, Schlaeffer F (2002) Extended-spectrum beta-lactamase producing Enterobacteriaceae strains in southern Israel. Med Sci Monit 8:CR44-CR47
13. Navon-Venezia S, Hammer-Munz O, Schwartz D, Turner D, Kuzmenko B, Carmeli Y (2003) Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clin Microbiol 41:155-158
14. Colodner R, Raz R, Chazan B, Sakran W (2004) Susceptibility pattern of extended spectrum β-lactamase producing bacteria isolated from inpatients to five antimicrobial drugs in a community hospital in Northern Israel. Int J Antimicrob Agents 24:409-410
15. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R (2005) Prevalence and risk factors of extended-spectrum-producing Escherichia coli and Klebsiella pneumoniae in an Israeli longterm care facility. Eur J Microbiol Infect Dis 24:17-22
16. Vasilev V, Japheth R, Yishai R, Andorn N (2004) Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000-2002. Epidemiol Infect 132:1049-1054
17. Bauer AW, Kirby WM, Sherris JC, Turk N (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 36:493-496
18. National Committee for Clinical Laboratory Standards (1999) Performance standards for antimicrobial susceptibility testing. Approved standard M100-S9. NCCLS, Wayne, PA
19. National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial susceptibility testing. 13th informational supplement. Document M100-S13 (M2), for use with M2-A8-Disk Diffusion. NCCLS, Wayne, PA
20. National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. NCCLS, Wayne, PA
21. European Antimicrobial Resistance Surveillance System (2004) Protocol for ESBL reporting. EARSS manual. National Institute of Public Health and Environmental Hygiene (RIVM), Bilthoven, the Netherlands, pp 26-27
22. Thomson K, Molland E (2004) Newer β-lactamases: clinical and laboratory implications (in-house manual). Center for Research in Antiinfectives and Biotechnology. Department of Medical Microbiology and Immunology, Creighton University School of Medicine. Omaha, Nebraska, pp 5-6
23. Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y (1993) Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob Agents Chemother 37:851-858
24. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ (2000) CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 14:137-142
25. Poirel P, Gniadkowski M, Nordman P (2002) Biochemical analysis of the ceftazidime-hydrolising extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother 50:1031-1034
26. Stürenburg E, Mack D (2003) Extended-spectrum β-lactamases: implications for the clinical microbiological laboratory, therapy and infection control. J Infect 47:273-295
27. Schlesinger Y, Navon-Venezia S, Chmelnitsky I, Hammer-Münz O, Leavitt A, Gold HS, Schwaber MJ, Carmeli Y (2005) Characterization of extended-spectrum beta-lactamases (ESBLs) among Enterobacter isolates in Tel-Aviv. Antimicrob Agents Chemother 49:1150-1156
28. Nordmann P, Naas T (1994) Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class-A beta-lactamases. Antimicrob Agents Chemother 38:104-114
29. Bauerfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM (1996) Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob Agents Chemother 40:509-513
30. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, William PP, Brittain KL, Oliver A, McGowan JE, Tenover FC (2001) Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J Clin Microbiol 39:2864-2872
31. Chmelnitsky I, Carmeli Y, Leavitt A, Schwaber MJ, Navon-Venezia S (2005) CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones from Tel-Aviv. Antimicrob Agents Chemother 49:4745-4750
32. Sabate M, Tarrago R, Navarro F, Miro E, Verges C, Barbe J, Prats G (2000) Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 44:1970-1973
33. Quellette M, Bissonnette L, Roy PH (1997) Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 β-lactamase gene. Proc Natl Acad Sci USA 84:7378-7387
34. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Phillipon A, Arlet G (2004) Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249-1255
35. Kim S, Kim J, Kang Y, Park Y, Lee B (2004) Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea. J Clin Microbiol 42:5264-5269
36. Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S (2003) CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 35:503-505
37. Pai H, Choi EC, Lee HJ, Hong JY, Jacoby GA (2001) Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli and Klebsiella pneumoniae in Korea. J Clin Microbiol 39:3747-3749
38. Radice M, Gonzales C, Power MC, Vidal P, Gutkind G (2001) Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg Infect Dis 7:442-443
39. Navia MM, Capitano L, Ruiz J, Vargas M, Urassa H, Schellemberg D, Gascon J, Vila J (1999) Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol 37:3113-3117
40. Siu LK, Lo JYC, Yuen PY, Chau MHNG, Ho PL (2000) β-Lactamases in Shigella flexneri isolated from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase, OXA-30. Antimicrob Agents Chemother 44:2034-2038
41. Sirot D, Chanal C, Bennet R, Champs CD, Sirot J (2001) Inhibitor-resistant TEM-33 β-lactamase in a Shigella sonnei isolate. Antimicrob Agents Chemother 45:2179-2180
42. Peirano G, Agersø Y, Aarestrup FM, Rodrigues DP (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55:301-305
43. Leverstein-van Hall MA, Fluit AC, Paauw A, Box ATA, Brisse S, Verhoef J (2002) Evaluation of the E test ESBL and BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol 40:3703-3711
44. Lartigue M, Poirel L, Decousser J, Nordman P (2005) Multidrug-resistant Shigella sonnei and Salmonella enterica serotype typhimurium isolates producing CTX-M β-lactamases as causes of community-acquired infection in France. Clin Infect Dis 40:1069-1070